Topol and Teirstein: The Click and Rub Show http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub Cardiologists, Drs Eric Topol and Paul Teirstein, from Scripps (STRI), review the latest cardiology news and events in this freewheeling, unconventional exchange. en-us theheart.org theheart.org info@theheart.org http://radio.theheart.org/images/Topol-and-Teirstein-Click-and-Rub/rss_banner_url.jpg Cardiologists, Drs Eric Topol and Paul Teirstein, from Scripps (STRI), review the latest cardiology news and events in this freewheeling, unconventional exchange. http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub Science & Medicine/Medicine #10: What case for live cases? Topol and Teirstein: The Click and Rub Show info@theheart.org (theheart.org) From the floor of the TCT convention center, Drs Eric Topol and Paul Teirstein ponder live cases: immoral grandstanding or important learning and treatment opportunity?<img src="http://feeds.feedburner.com/~r/Topol-And-Teirstein-Click-and-Rub/~4/kcmoIUMOCO0" height="1" width="1"/> From the floor of the TCT convention center, Drs Eric Topol and Paul Teirstein ponder live cases: immoral grandstanding or important learning and treatment opportunity?

See also:

Dehmer GJ, Douglas JS, Abizaid A, et al. SCAI/ACCF/HRS/ESC/SOLACI/APSIC Statement on the Use of Live Case Demonstrations at Cardiology Meetings Assessments of the past and standards for the future. J Am Coll Cardiol, 2010; 56:1267-1282. Available here.

A script for the show: Live cases in cardiology get a code of conduct

]]> Mon, 14 Nov 2011 09:35:00 -0500 http://feedproxy.google.com/~r/Topol-And-Teirstein-Click-and-Rub/~3/kcmoIUMOCO0/10-what-case-for-live-cases http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2011/11/13/10-what-case-for-live-cases http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2011/11/13/10-what-case-for-live-cases#comments Topol and Teirstein: The Click and Rub Show http://radio.theheart.org/images/thumbnails/10-what-case-for-live-cases.jpg http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=313837297 2 TCT 2011 TCT 2011 http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2011/11/13/10-what-case-for-live-cases #9: Behind the scenes of hospital ranking Topol and Teirstein: The Click and Rub Show info@theheart.org (theheart.org) What constitutes a "top hospital"? Drs Eric Topol and Paul Teirstein review the notion of hospital ranking and the criteria used to select "top hospitals" in the renowned US News and World Report listing, the recent Joint Commission annual report, and the<img src="http://feeds.feedburner.com/~r/Topol-And-Teirstein-Click-and-Rub/~4/gdGCHVRM9us" height="1" width="1"/> What constitutes a "top hospital"? Drs Eric Topol and Paul Teirstein review the notion of hospital ranking and the criteria used to select "top hospitals" in the renowned US News and World Report listing, the recent Joint Commission annual report, and the Thomson Reuters top hospital picks.

Does a top-ranked hospital necessarily deliver the best care?

See:

 

]]> Tue, 04 Oct 2011 15:50:00 -0400 http://feedproxy.google.com/~r/Topol-And-Teirstein-Click-and-Rub/~3/gdGCHVRM9us/9-behind-the-scenes-of-hospital-ranking http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2011/10/4/9-behind-the-scenes-of-hospital-ranking http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2011/10/4/9-behind-the-scenes-of-hospital-ranking#comments Topol and Teirstein: The Click and Rub Show http://radio.theheart.org/images/thumbnails/9-behind-the-scenes-of-hospital-ranking.jpg http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=313837297 4 http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2011/10/4/9-behind-the-scenes-of-hospital-ranking #8: Appropriateness: Defining, discussing, enforcing Topol and Teirstein: The Click and Rub Show info@theheart.org (theheart.org) Study results recently published by Chan et al in JAMA point to remarkably good rates of appropriate use of PCI. But how meaningful is the definition of "appropriate"? How enlightening are the results? The debate continues . . .<img src="http://feeds.feedburner.com/~r/Topol-And-Teirstein-Click-and-Rub/~4/biaxgcYmHMs" height="1" width="1"/> Study results recently published by Chan et al in JAMA point to remarkably good rates of appropriate use of PCI. But how meaningful is the definition of "appropriate"? How enlightening are the results? The debate continues . . . 

See:

Almost all acute PCI and half of nonacute PCI in US meet appropriateness guidelines

Chan P, Patel M, Klein LW, et al. Appropriateness of percutaneous coronary intervention. JAMA 2011; 306:53-61. Abstract.

European perspectives on appropriate use of PCI

Doing the right thing: Appropriate use of PCI

]]> Mon, 11 Jul 2011 17:00:00 -0400 http://feedproxy.google.com/~r/Topol-And-Teirstein-Click-and-Rub/~3/biaxgcYmHMs/8-appropriateness-defining-discussing-enforcing http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2011/7/11/8-appropriateness-defining-discussing-enforcing http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2011/7/11/8-appropriateness-defining-discussing-enforcing#comments Topol and Teirstein: The Click and Rub Show http://radio.theheart.org/images/thumbnails/8-appropriateness-defining-discussing-enforcing.jpg http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=313837297 0 http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2011/7/11/8-appropriateness-defining-discussing-enforcing #7: What good is evidence-based medicine? Topol and Teirstein: The Click and Rub Show info@theheart.org (theheart.org) The backbone of cardiovascular research is the randomized clinical trial, which at great expense and effort seeks to enroll thousands of patients in the pursuit of an absolute reduction that is frequently around 1%. Is it really worth it?<img src="http://feeds.feedburner.com/~r/Topol-And-Teirstein-Click-and-Rub/~4/QzvjPn-fkWA" height="1" width="1"/> The backbone of cardiovascular research is the randomized clinical trial, which at great expense and effort seeks to enroll thousands of patients in the pursuit of an absolute reduction that is frequently around 1%. Is it really worth it? Is it time to find a new paradigm?

]]> Thu, 11 Nov 2010 10:55:00 -0500 http://feedproxy.google.com/~r/Topol-And-Teirstein-Click-and-Rub/~3/QzvjPn-fkWA/episode-7-what-good-is-evidencebased-medicine http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2010/11/10/episode-7-what-good-is-evidencebased-medicine http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2010/11/10/episode-7-what-good-is-evidencebased-medicine#comments Topol and Teirstein: The Click and Rub Show http://radio.theheart.org/images/thumbnails/episode-7-what-good-is-evidencebased-medicine.jpg http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=313837297 4 http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2010/11/10/episode-7-what-good-is-evidencebased-medicine #6: To angiogram or not to angiogram? Topol and Teirstein: The Click and Rub Show info@theheart.org (theheart.org) <p>In this episode <strong>Drs Topol</strong> and <strong>Teirstein</strong> examine the merits of elective coronary angiography: A test that adds little diagnostic value? Or a diagnostic tool that has its place if used judiciously? They mull over the statistical analysis in Patel et al's recent paper, discuss when elective angiography may be the correct line of action, consider why detractors have been accused of a broadsiding PCI, and reflect on the insight of Teirstein's mother following her recent angiogram. </p><p>What are your thoughts on elective coronary angiography? </p> <p><span>See:</span></p> <p><span>Patel MR, Peterson ED, Dai D, et al. </span><span>Low diagnostic yield of elective coronary angiography. <em>N Engl J Med</em>. 2010 Mar 11;362(10):886-95. <a href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;TransSchema=title&amp;term=NEJM%5bJour%5d%20AND%202010%2F03%2F11%5bpdat%5d%20AND%20angiography">Abstract</a>.</span></p> <p><a href="http://www.theheart.org/article/1054105.do" title="An NCDR study of diagnostic yield of coronary angiography finds only about a third of patients undergoing elective cardiac catheterization have obstructive disease.">Noninvasive testing adds little to risk-factor screening for predicting obstructive CAD </a></p><img src="http://feeds.feedburner.com/~r/Topol-And-Teirstein-Click-and-Rub/~4/CEfQ-Ye7xUo" height="1" width="1"/> In this episode Drs Topol and Teirstein examine the merits of elective coronary angiography: A test that adds little diagnostic value? Or a diagnostic tool that has its place if used judiciously? They mull over the statistical analysis in Patel et al's recent paper, discuss when elective angiography may be the correct line of action, consider why detractors have been accused of a broadsiding PCI, and reflect on the insight of Teirstein's mother following her recent angiogram.

What are your thoughts on elective coronary angiography?

See:

Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010 Mar 11;362(10):886-95. Abstract.

Noninvasive testing adds little to risk-factor screening for predicting obstructive CAD

]]> In this episode Drs Topol and Teirstein examine the merits of elective coronary angiography: A test that adds little diagnostic value? Or a diagnostic tool that has its place if used judiciously? They mull over the statistical analysis in Patel et al's recent paper, discuss when elective angiography may be the correct line of action, consider why detractors have been accused of a broadsiding PCI, and reflect on the insight of Teirstein's mother following her recent angiogram.

What are your thoughts on elective coronary angiography?

See:

Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010 Mar 11;362(10):886-95. Abstract.

Noninvasive testing adds little to risk-factor screening for predicting obstructive CAD

]]> Tue, 18 May 2010 16:15:00 -0400 http://feedproxy.google.com/~r/Topol-And-Teirstein-Click-and-Rub/~3/CEfQ-Ye7xUo/episode-6-to-angiogram-or-not-to-angiogram http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2010/5/18/episode-6-to-angiogram-or-not-to-angiogram http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2010/5/18/episode-6-to-angiogram-or-not-to-angiogram#comments Topol and Teirstein: The Click and Rub Show http://radio.theheart.org/images/thumbnails/episode-6-to-angiogram-or-not-to-angiogram.jpg http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=313837297 11 http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2010/5/18/episode-6-to-angiogram-or-not-to-angiogram #5: Clinton, Cheney and coronary disease Topol and Teirstein: The Click and Rub Show info@theheart.org (theheart.org) </p><p>Celebrities with heart disease provoke heated debate among cardiologists as well as the general public, as shown by the interest in <strong>Bill Clinton</strong>'s recent stent implantation. <strong>Drs Topol</strong> and <strong>Teirstein </strong>examine this case and <strong>Dick Cheney</strong>'s history of heart disease and review some enlightening comments posted to the online forum on <strong>theheart.org</strong>. Join this discussion for a review of Clinton's angiograms from 2004, glucose tolerance testing, secondary prevention, pomegranate juice, personal butchers, and hybrid procedures.</p> <p>&nbsp;</p><img src="http://feeds.feedburner.com/~r/Topol-And-Teirstein-Click-and-Rub/~4/DILuvIMV8WA" height="1" width="1"/>

Celebrities with heart disease provoke heated debate among cardiologists as well as the general public, as shown by the interest in Bill Clinton's recent stent implantation. Drs Topol and Teirstein examine this case and Dick Cheney's history of heart disease and review some enlightening comments posted to the online forum on theheart.org. Join this discussion for a review of Clinton's angiograms from 2004, glucose tolerance testing, secondary prevention, pomegranate juice, personal butchers, and hybrid procedures.

 

]]>

Celebrities with heart disease provoke heated debate among cardiologists as well as the general public, as shown by the interest in Bill Clinton's recent stent implantation. Drs Topol and Teirstein examine this case and Dick Cheney's history of heart disease and review some enlightening comments posted to the online forum on theheart.org. Join this discussion for a review of Clinton's angiograms from 2004, glucose tolerance testing, secondary prevention, pomegranate juice, personal butchers, and hybrid procedures.

 

]]> Tue, 02 Mar 2010 14:40:00 -0500 http://feedproxy.google.com/~r/Topol-And-Teirstein-Click-and-Rub/~3/DILuvIMV8WA/episode-5-clinton-cheney-and-coronary-disease http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2010/3/2/episode-5-clinton-cheney-and-coronary-disease http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2010/3/2/episode-5-clinton-cheney-and-coronary-disease#comments Topol and Teirstein: The Click and Rub Show http://radio.theheart.org/images/thumbnails/episode-5-clinton-cheney-and-coronary-disease.jpg http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=313837297 0 http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2010/3/2/episode-5-clinton-cheney-and-coronary-disease #4: Why is medicine resistant to change? Topol and Teirstein: The Click and Rub Show info@theheart.org (theheart.org) <p>Medicine is frequently slow to adapt to change. In this philosophical exchange, Drs Topol and Teirstein seek to explain the phenomenon by examining evidence-based medicine, direct-to-consumer advertising, hectic schedules, general conservatism, randomized trials, physician incentives, and pay-for-performance.</p><img src="http://feeds.feedburner.com/~r/Topol-And-Teirstein-Click-and-Rub/~4/nY3AKsPscJI" height="1" width="1"/> Medicine is frequently slow to adapt to change. In this philosophical exchange, Drs Topol and Teirstein seek to explain the phenomenon by examining evidence-based medicine, direct-to-consumer advertising, hectic schedules, general conservatism, randomized trials, physician incentives, and pay-for-performance.

]]> Medicine is frequently slow to adapt to change. In this philosophical exchange, Drs Topol and Teirstein seek to explain the phenomenon by examining evidence-based medicine, direct-to-consumer advertising, hectic schedules, general conservatism, randomized trials, physician incentives, and pay-for-performance.

]]> Thu, 29 Oct 2009 13:30:00 -0400 http://feedproxy.google.com/~r/Topol-And-Teirstein-Click-and-Rub/~3/nY3AKsPscJI/episode-4-why-is-medicine-resistant-to-change http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2009/10/27/episode-4-why-is-medicine-resistant-to-change http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2009/10/27/episode-4-why-is-medicine-resistant-to-change#comments Topol and Teirstein: The Click and Rub Show http://radio.theheart.org/images/thumbnails/episode-4-why-is-medicine-resistant-to-change.jpg http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=313837297 4 http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2009/10/27/episode-4-why-is-medicine-resistant-to-change #3: Percutaneous aortic-valve procedures Topol and Teirstein: The Click and Rub Show info@theheart.org (theheart.org) </p><p>From fiction to fact: in the near future most aortic-valve procedures will be percutaneous. Join <strong>Drs Topol</strong> and <strong>Teirstein</strong> for a light hearted discussion that&mdash;while also evoking harpoons and pulp fiction&mdash;illustrates why this procedure is transformational for patient outcomes, a welcome collaboration between interventionalist and vascular surgeon, and the path forward for aortic-valve replacement.</p> <p>&nbsp;</p><img src="http://feeds.feedburner.com/~r/Topol-And-Teirstein-Click-and-Rub/~4/0b5ND-kRYtM" height="1" width="1"/>

From fiction to fact: in the near future most aortic-valve procedures will be percutaneous. Join Drs Topol and Teirstein for a light hearted discussion that—while also evoking harpoons and pulp fiction—illustrates why this procedure is transformational for patient outcomes, a welcome collaboration between interventionalist and vascular surgeon, and the path forward for aortic-valve replacement.

 

]]>

From fiction to fact: in the near future most aortic-valve procedures will be percutaneous. Join Drs Topol and Teirstein for a light hearted discussion that—while also evoking harpoons and pulp fiction—illustrates why this procedure is transformational for patient outcomes, a welcome collaboration between interventionalist and vascular surgeon, and the path forward for aortic-valve replacement.

 

]]> Wed, 29 Jul 2009 11:30:00 -0400 http://feedproxy.google.com/~r/Topol-And-Teirstein-Click-and-Rub/~3/0b5ND-kRYtM/epdisode-3-percutaneous-aortic-valve-procedures http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2009/7/28/epdisode-3-percutaneous-aortic-valve-procedures http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2009/7/28/epdisode-3-percutaneous-aortic-valve-procedures#comments Topol and Teirstein: The Click and Rub Show http://radio.theheart.org/images/thumbnails/epdisode-3-percutaneous-aortic-valve-procedures.jpg http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=313837297 1 http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2009/7/28/epdisode-3-percutaneous-aortic-valve-procedures #2: Dissecting "the cost conundrum": McAllen, Gawande, Obama, and healthcare reform in the US Topol and Teirstein: The Click and Rub Show info@theheart.org (theheart.org) <p>The media is buzzing with discussions of <strong>Dr Atul Gawande</strong>'s article in the <em>New Yorker</em> <a href="http://www.newyorker.com/reporting/2009/06/01/090601fa_fact_gawande">magazine</a>, which looks at the astounding healthcare costs in the town of McAllen, TX. How did this &quot;outlier&quot; capture the attention of the nation and fuel the debate for healthcare reform? Is the debate fair and balanced or rather tainted by journalistic hyperbole?</p><img src="http://feeds.feedburner.com/~r/Topol-And-Teirstein-Click-and-Rub/~4/4K6rsNt1RoY" height="1" width="1"/> The media is buzzing with discussions of Dr Atul Gawande's article in the New Yorker magazine, which looks at the astounding healthcare costs in the town of McAllen, TX. How did this "outlier" capture the attention of the nation and fuel the debate for healthcare reform? Is the debate fair and balanced or rather tainted by journalistic hyperbole?

]]> The media is buzzing with discussions of Dr Atul Gawande's article in the New Yorker magazine, which looks at the astounding healthcare costs in the town of McAllen, TX. How did this "outlier" capture the attention of the nation and fuel the debate for healthcare reform? Is the debate fair and balanced or rather tainted by journalistic hyperbole?

]]> Mon, 29 Jun 2009 15:13:00 -0400 http://feedproxy.google.com/~r/Topol-And-Teirstein-Click-and-Rub/~3/4K6rsNt1RoY/dissecting-the-cost-conundrum-mcallen-gawande-obama-and-healthcare-reform-in-the-us http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2009/6/29/dissecting-the-cost-conundrum-mcallen-gawande-obama-and-healthcare-reform-in-the-us http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2009/6/29/dissecting-the-cost-conundrum-mcallen-gawande-obama-and-healthcare-reform-in-the-us#comments Topol and Teirstein: The Click and Rub Show http://radio.theheart.org/images/thumbnails/dissecting-the-cost-conundrum-mcallen-gawande-obama-and-healthcare-reform-in-the-us.jpg http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=313837297 2 http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2009/6/29/dissecting-the-cost-conundrum-mcallen-gawande-obama-and-healthcare-reform-in-the-us #1: Revascularization trials: Bypass vs PCI Topol and Teirstein: The Click and Rub Show info@theheart.org (theheart.org) <p>In this inaugural episode, <strong>Drs Topol</strong> and <strong>Teirstein</strong> focus on <strong>SYNTAX</strong>. From the basic questions--Does the trial have value? Has it affected clinical practice?--to the problematic issue of randomizing patients to a 20-minute intervention or a weeklong hospitalization, they also ponder what they have learned from revascularization trials and paper cuts as well as the whimsical image of performing PCI on CV surgeons.</p><img src="http://feeds.feedburner.com/~r/Topol-And-Teirstein-Click-and-Rub/~4/VeQPHjP3WXw" height="1" width="1"/> In this inaugural episode, Drs Topol and Teirstein focus on SYNTAX. From the basic questions--Does the trial have value? Has it affected clinical practice?--to the problematic issue of randomizing patients to a 20-minute intervention or a weeklong hospitalization, they also ponder what they have learned from revascularization trials and paper cuts as well as the whimsical image of performing PCI on CV surgeons.

]]> In this inaugural episode, Drs Topol and Teirstein focus on SYNTAX. From the basic questions--Does the trial have value? Has it affected clinical practice?--to the problematic issue of randomizing patients to a 20-minute intervention or a weeklong hospitalization, they also ponder what they have learned from revascularization trials and paper cuts as well as the whimsical image of performing PCI on CV surgeons.

]]> Mon, 04 May 2009 10:40:00 -0400 http://feedproxy.google.com/~r/Topol-And-Teirstein-Click-and-Rub/~3/VeQPHjP3WXw/episode1 http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2009/4/20/episode1 http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2009/4/20/episode1#comments Topol and Teirstein: The Click and Rub Show http://radio.theheart.org/images/thumbnails/episode1.jpg http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=313837297 3 http://radio.theheart.org/Topol-and-Teirstein-Click-and-Rub/2009/4/20/episode1 theheart.orgnonadultCardiologists, Drs Eric Topol and Paul Teirstein, from Scripps (STRI), review the latest cardiology news and events in this freewheeling, unconventional exchange.